Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

Javier I. Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, Ana Henriques, Esther Viñas, Carlos Prieto, Laura Sánchez-Muñoz, Carolina Caldas, Andrea Mayado, Almudena Matito, Noelia Dasilva-Freire, Alberto Orfao, Andrés C. García-Montero

Blood (2019) 134 (5): 456–468.

https://doi.org/10.1182/blood.2018886507

Published: 2019

Includes: Supplemental data

Journal Articles

Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM)

Blood (2017) 130 (Supplement 1): 1650.

https://doi.org/10.1182/blood.V130.Suppl_1.1650.1650

Published: 2017

Journal Articles

Distinct Diagnostic and Clinical Features of Bone Marrow Mastocytosis: A Study of the Registry of the European Competence Network on Mastocytosis (ECNM)

Massimiliano Bonifacio, MD, Patrizia Bonadonna, MD, Hanneke Oude Elberink, MD, Björn van Anrooij, MD, Aleksandra Górska, MD, Magdalena Lange, MD, Emir Hadzijusufovic, DVM, Luigi Scaffidi, Ilaria Tanasi, MD, Cecelia Perkins, Virginia Valeria Ferretti, Anja Illerhaus, PhD, Thilo Jakob, MD, Roberta Parente, MD, Mohamad Jawhar, MD, Francesca Caroppo, MD, Alexander Zink, MD, Alex Kilbertus, MD, Akif Selim Yavuz, MD, Michael Doubek, MD PhD, Hans Hagglund, MD PhD, Jens P. Panse, MD, Vito Sabato, MD PhD, Elisabeth Aberer, MD, Nadja Jaekel, MD, Peter Vandenberghe, MD PhD, David Fuchs, MD, Knut Brockow, MD, Anna Belloni Fortina, MD, Andreas Reiter, MD, Massimo Triggiani, MD, Khalid Shoumariyeh, MD, Karin Hartmann, MD, Chiara Elena, Olivier Hermine, MD PhD, Jason Gotlib, MD, Marek Niedoszytko, MD, Hanneke Kluin-Nelemans, MD PhD, Wolfgang R. Sperr, MD, Peter Valent, MD, Roberta Zanotti, MD

Blood (2017) 130 (Supplement 1): 4200.

https://doi.org/10.1182/blood.V130.Suppl_1.4200.4200

Published: 2017

Journal Articles

Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)

Blood (2016) 128 (22): 396.

https://doi.org/10.1182/blood.V128.22.396.396

Published: 2016

Journal Articles

Aleukemic Mast Cell Leukemia (aMCL) - Clinical Characteristics and Outcomes

Preetesh Jain, MBBS, MDDM, PhD, Sa Wang, MD, Hagop M. Kantarjian, MD, Nawid Sarwari, Keyur P. Patel, MD PhD, Prithviraj Bose, MD, Sherry Pierce, BSN, BA, Tapan M. Kadia, MD, Naval Daver, MD, Naveen Pemmaraju, MD, Jorge E. Cortes, MD, Srdan Verstovsek, MD PhD

Blood (2016) 128 (22): 4255.

https://doi.org/10.1182/blood.V128.22.4255.4255

Published: 2016

Journal Articles

KIT D816V–mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression

Andres C. Garcia-Montero, Maria Jara-Acevedo, Ivan Alvarez-Twose, Cristina Teodosio, Laura Sanchez-Muñoz, Carmen Muñiz, Javier I. Muñoz-Gonzalez, Andrea Mayado, Almudena Matito, Carolina Caldas, Jose M. Morgado, Luis Escribano, Alberto Orfao

Blood (2016) 127 (6): 761–768.

https://doi.org/10.1182/blood-2015-07-655100

Published: 2016

Journal Articles

KIT D816V Mutation Positive Bone Marrow Mesenchymal Stem Cells in Indolent Systemic Mastocytosis Are Associated with Disease Progression

Andres C Garcia-Montero, PhD, Maria Jara-Acevedo, MSc, Ivan Alvarez-Twose, MD, Cristina Teodosio, Laura Sanchez-Muñoz, Javier Ignacio Muñoz-Gonzalez, Andrea Mayado, Almudena Matito, MD PhD, Carolina Caldas, Jose M Morgado, MSc, Luis Escribano, MD PhD, Alberto Orfao, MD PhD

Blood (2015) 126 (23): 4058.

https://doi.org/10.1182/blood.V126.23.4058.4058

Published: 2015

Journal Articles

Mast Cell Disease and Blood Coagulation Abnormalities: Discussion on 14 Cases and Review of the Literature

Ana Carvalhosa, Gandhi Damaj, MD PhD, Danielle Canioni, MD, Laure Cabaret, Nathalie Costédoat-Chalumeau, MD PhD, Pascal Cathebras, MD, Stéphane Durupt, MD, Isabelle Durieu, MD PhD, Emmanuel Gyan, MD PhD, David Launay, MD PhD, Benoit Pilmis, MD, Laurent Frenzel, MD, Olivier Lortholary, MD PhD, Olivier Hermine, MD PhD, Cedric R. Hermans, MD PhD, Marie-Olivia Chandesris, MD

Blood (2014) 124 (21): 2856.

https://doi.org/10.1182/blood.V124.21.2856.2856

Published: 2014

Journal Articles

Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis

Blood (2014) 124 (21): 1856.

https://doi.org/10.1182/blood.V124.21.1856.1856

Published: 2014

Journal Articles

Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412

Paula De Melo Campos, MD, João Agostinho Machado-Neto, MSc, Adriana Silva Santos Duarte, PhD, Renata Scopim-Ribeiro, BSc, Flavia Fonseca de Carvalho Barra, MD, José Vassallo, MD, PhD, Irene Lorand-Metze, MD, PhD, Ramon V. Tiu, MD, Fernando Ferreira Costa, MD, PhD, Sara T O Saad, MD, PhD, Fabiola Traina, M.D., Ph.D.

Blood (2013) 122 (21): 5267.

https://doi.org/10.1182/blood.V122.21.5267.5267

Published: 2013

Journal Articles

Anti CD-30 Antibody-Drug Conjugate Brentuximab Vedotin (ADCETRIS ® ) May Be a Promising Treatment Option for Systemic Mastocytosis (SM).

Amitkumar Mehta, Vishnu V B Reddy, MD, Uma Borate, MD, MS

Blood (2012) 120 (21): 2857.

https://doi.org/10.1182/blood.V120.21.2857.2857

Published: 2012

Journal Articles

Improved Detection of the KIT D816V Mutation Using a Real-Time PCR Assay Allows a Finer Recognition of Patients with Indolent Systemic Mastocytosis

Massimiliano Bonifacio, Giovanna De Matteis, Caterina De Benedittis, Omar Perbellini, Alberto Zamò, Patrizia Bonadonna, Elisa Paviati, Anna Artuso, Simona Soverini, Giovanni Pizzolo, Giovanni Martinelli, MD, PhD, Roberta Zanotti

Blood (2011) 118 (21): 5163.

https://doi.org/10.1182/blood.V118.21.5163.5163

Published: 2011

Journal Articles

UK Single Instituition Experience of Mastocytosis: Guys and St Thomas' NHS Foundation Trust

Nandini Sadasivam, Mufaddal Moonim, Clive Grattan, Jonathan White, Bridget Wilkins, Jon van Der Walt, Nicholas C.P. Cross, Claire N. Harrison, Jennifer Thomson, Deepti Radia

Blood (2010) 116 (21): 5052.

https://doi.org/10.1182/blood.V116.21.5052.5052

Published: 2010

Journal Articles

New TET2 , ASXL1 and CBL Mutations Have Poor Prognostic Impact In Systemic Mastocytosis and Related Disorders

Fabiola Traina, MD, PhD, Ania Jankowska, MSC, Hideki Makishima, MD, PhD, Fred H. Hsieh, MD, Yingchun Han, PhD, Christine O'Keefe, PhD, Yuka Sugimoto, MD, PhD, Sanjay R. Mohan, MD, Hadrian Szpurka, PhD, Courtney Prince, Kathryn Guinta, MSC, Mikkael A. Sekeres, MD, MS, Matt Kalaycio, MD, Alan E. Lichtin, MD, Anjali S. Advani, MD, Edward Copelan, MD, Ronald Sobecks, MD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Ramon V. Tiu, MD

Blood (2010) 116 (21): 3076.

https://doi.org/10.1182/blood.V116.21.3076.3076

Published: 2010

Journal Articles

Clinical, Biological, and Molecular Characteristics of Well-Differentiated Systemic Mastocytosis: a study in 18 Patients by Spanish Network on Mastocytosis (REMA)

Iván Alvarez-Twose, Laura Sánchez-Muñoz, María Jara-Acevedo, Cristina Teodosio, Andrés García-Montero, Mónica García-Cosio, Manuela Mollejo, Alberto Orfao, Luis María Escribano

Blood (2008) 112 (11): 5246.

https://doi.org/10.1182/blood.V112.11.5246.5246

Published: 2008

Journal Articles

Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).

Akif S. Yavuz, Nilüfer Alpay, Öner Dogan, Nesimi Büyükbabani, Can Baykal, Dilsad Sindel, Yüksel Pekçelen, Refik Tanakol

Blood (2007) 110 (11): 4662.

https://doi.org/10.1182/blood.V110.11.4662.4662

Published: 2007

Journal Articles

Clinical Course and Prognosis in Mast Cell Proliferative Disorders: A 17 Year Experience in a Single Center.

Wolfgang R. Sperr, MD, Friedrich Wimazal, MD, Alexandra Boehm, MD, Alexander W. Hauswirth, MD, Stefan Florian, Robert Fritsche-Polanz, MD, Manuela Foedinger, MD, Peter Valent, MD

Blood (2004) 104 (11): 4741.

https://doi.org/10.1182/blood.V104.11.4741.4741

Published: 2004

Journal Articles

Neutrophil and Eosinophil PRV-1 Expression in Atypical Myeloproliferative Disorders.

Shireen Sirhan, Terra L. Lasho, Michelle A. Elliott, Ayalew Tefferi

Blood (2004) 104 (11): 1521.

https://doi.org/10.1182/blood.V104.11.1521.1521

Published: 2004

Journal Articles

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c- kit gene

A. Selim Yavuz, Peter E. Lipsky, Sule Yavuz, Dean D. Metcalfe, Cem Akin

Blood (2002) 100 (2): 661–665.

https://doi.org/10.1182/blood-2002-01-0203

Published: 2002

NARROW

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM)

Distinct Diagnostic and Clinical Features of Bone Marrow Mastocytosis: A Study of the Registry of the European Competence Network on Mastocytosis (ECNM)

Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry)

Aleukemic Mast Cell Leukemia (aMCL) - Clinical Characteristics and Outcomes

KIT D816V–mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression

KIT D816V Mutation Positive Bone Marrow Mesenchymal Stem Cells in Indolent Systemic Mastocytosis Are Associated with Disease Progression

Mast Cell Disease and Blood Coagulation Abnormalities: Discussion on 14 Cases and Review of the Literature

Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis

Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412

Anti CD-30 Antibody-Drug Conjugate Brentuximab Vedotin (ADCETRIS ® ) May Be a Promising Treatment Option for Systemic Mastocytosis (SM).

Improved Detection of the KIT D816V Mutation Using a Real-Time PCR Assay Allows a Finer Recognition of Patients with Indolent Systemic Mastocytosis

UK Single Instituition Experience of Mastocytosis: Guys and St Thomas' NHS Foundation Trust

New TET2 , ASXL1 and CBL Mutations Have Poor Prognostic Impact In Systemic Mastocytosis and Related Disorders

Clinical, Biological, and Molecular Characteristics of Well-Differentiated Systemic Mastocytosis: a study in 18 Patients by Spanish Network on Mastocytosis (REMA)

Analysis of Bone Mineral Density, Biochemical Bone Turnover Markers and Serum Tryptase Levels in Patients with Systemic Mastocytosis (SM).

Clinical Course and Prognosis in Mast Cell Proliferative Disorders: A 17 Year Experience in a Single Center.

Neutrophil and Eosinophil PRV-1 Expression in Atypical Myeloproliferative Disorders.

Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c- kit gene

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only